CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to reduce the likelihood that it will reach the dreaded "difficult-to-treat" stage ...
Please provide your email address to receive an email when new articles are posted on . In this video, Philip J. Mease, MD, discusses a Nordic registry study presented at the EULAR annual meeting that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results